Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
02/2003
02/04/2003US6514997 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
02/04/2003US6514981 Methods of modulating tyrosine protein kinase function with indolinone compounds
02/04/2003US6514977 For treating p38 kinase mediated disorders
02/04/2003US6514970 Urotensin-II receptor antagonists
02/04/2003US6514968 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising
02/04/2003US6514633 Light emitting device material, light emitting device using thereof, and amine compound
01/2003
01/31/2003CA2354486A1 C7 ester substituted taxanes
01/31/2003CA2354478A1 C10 carbonate substituted taxanes
01/31/2003CA2354471A1 C10 ester substituted taxanes
01/30/2003WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
01/30/2003WO2003008405A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres
01/30/2003WO2003008372A1 Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
01/30/2003WO2003007959A1 Quinoxaline derivatives which have parp inhibitory action
01/30/2003WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists
01/30/2003WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
01/30/2003WO2003007945A1 Viral polymerase inhibitors
01/30/2003WO2003007942A1 Substituted isoindoles and the use thereof
01/30/2003WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
01/30/2003WO2003007883A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
01/30/2003US20030023098 Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
01/30/2003US20030023069 Endogenous and non-endogenous versions of human G protein-coupled receptors
01/30/2003US20030022935 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents
01/30/2003US20030022925 5-(dialkylamine)alkoxy)-1H-pyrazole derivatives
01/30/2003US20030022920 1-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonist
01/30/2003US20030022907 Anxiolytic agents and analgesics
01/30/2003US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors
01/30/2003US20030022903 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/30/2003US20030022902 Based upon 2-(N-(7-benzyl-9-methyl-1,5-dioxonan-2,6-dione-3-yl)amido)-3-hydroxy-4 -methoxypyridine; use as agricultural fungicide
01/30/2003US20030022885 Pyrazole compounds useful as protein kinase inhibitors
01/30/2003US20030022794 Bioactive pesticides
01/30/2003CA2454007A1 Tetrahydroquinoxalines acting as bradykinin antagonists
01/30/2003CA2453650A1 Substituted isoindoles and the use thereof
01/30/2003CA2453636A1 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
01/30/2003CA2453613A1 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
01/30/2003CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
01/30/2003CA2453594A1 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
01/29/2003EP1279689A2 Mono-, Oligo and Poly-3-(1,1-difluoroalkyl)thiophenes and their use as charge transport materials
01/29/2003EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands
01/29/2003EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
01/29/2003EP1278744A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
01/29/2003EP1278743A1 Novel anti-infectives
01/29/2003EP1278742A1 Chromenylmethylpyrimidinediamines as antibacterial agents
01/29/2003EP1278741A1 Muscarinic agonists
01/29/2003EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
01/29/2003EP1278739A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
01/29/2003EP1278734A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
01/29/2003EP1278732A1 1-aroyl-piperidinyl benzamidines
01/29/2003EP1278520A1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
01/29/2003EP1278502A2 Protease inhibitors
01/29/2003EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
01/29/2003EP1105387B1 Prodrugs of proton pump inhibitors
01/29/2003EP1102761B1 Cyclopentabenzofuran derivatives and their use
01/29/2003EP1028948B1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
01/29/2003EP0983255B1 Substituted 2-benzoyl-cyclohexane-1,3-diones
01/29/2003EP0889884B1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
01/29/2003EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
01/29/2003EP0817772B1 Pyrrolidinyl hydroxamic acid compounds and their production process
01/29/2003EP0708769B1 Substituted 2-fused phenylpyridines with herbicidal activity
01/29/2003CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists
01/29/2003CN1394202A Picolinic acid derivatives and their use as fungicides
01/29/2003CN1100055C Piperazine and piperidine compounds
01/29/2003CN1100043C Sulfonamide derivative and process for preparing same
01/28/2003US6512122 Reacting a hexahalobenzene with a furan, thiophene, pyrrole, or cyclopropyl metallic derivative; hole transporting, green-light-emitting molecules
01/28/2003US6512001 D-proline derivatives
01/28/2003US6512000 Aminocarbonyl-substituted benzimidazoles having tryptase-inhibitory activity
01/28/2003US6511994 Modulators of CCR5 chemokine receptor activity
01/28/2003US6511978 Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations
01/28/2003US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia
01/28/2003US6511973 Enzyme inhibitors of blood coaggulation factor X for use as anticoaggulants in the treatment of cardiovascular diseases associated with thromboses
01/28/2003US6511942 Animal husbandry, veterinary medicine
01/24/2003CA2394209A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands
01/23/2003WO2003007071A2 Novel nonlinear optical compounds and polymers
01/23/2003WO2003007070A1 Novel nonlinear optical polymers incorporating amines
01/23/2003WO2003007069A2 Novel nonlinear optical polymers
01/23/2003WO2003006459A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
01/23/2003WO2003006457A1 Variolin derivatives and their use as antitumor agents
01/23/2003WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin
01/23/2003WO2003006437A1 Imidazole derivatives as adenosine deaminase inhibitors
01/23/2003WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
01/23/2003WO2003006016A2 Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury
01/23/2003WO2003005960A2 Novel bicyclic and tricyclic cannabinoids
01/23/2003WO2003005824A2 Substituted 3-heteroaryl (amino-or-oxy)-pyrrolidin-2-ones, method for the production thereof and use thereof as herbicides or as plant growth regulators
01/23/2003WO2003005823A2 Bromonitrothienyldioxans
01/23/2003WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors
01/23/2003WO2002046171A3 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
01/23/2003WO2002041835A3 Estrogen receptor modulators
01/23/2003WO2002036562A3 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
01/23/2003WO2002008177A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
01/23/2003WO2001051472A9 New imidazole derivatives
01/23/2003US20030018197 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection
01/23/2003US20030018189 Cyclic polyamines having total 9-24 members which have activity in against HIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors
01/23/2003US20030018064 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
01/23/2003US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
01/23/2003US20030018052 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/23/2003US20030018050 Indole and 2,3-dihydroindole derivatives, their preparation and use
01/23/2003US20030018046 Chemokine receptor binding heterocyclic compounds
01/23/2003US20030018045 Heterocyclic beta-3 adrenergic receptor agonists
01/23/2003US20030018035 Central nervous system disorders
01/23/2003US20030018033 Antiinflammatory agents; immunology; autoimmune diseases; rheumatic diseases
01/23/2003US20030018029 Tyrosine kinase inhbitor; antiproliferative agents